Last updated: August 06, 2026

Application No. 18/854,287

CRYSTALLINE FORM OF LANIFIBRANOR

Non-Final OA

Filed

Oct 04, 2024

Priority

Apr 05, 2022 — EU 22305456.0 +1 more

Examiner

KIFLE, BRUCK

Art Unit

Tech Center

Assignee

Inventiva

OA Round

1 (Non-Final)

Interview Optional

— +15.9% interview lift. Examiner has a relatively high allowance rate (79%); +15.9% interview lift. A written response may suffice.

Based on 1733 resolved cases, 2023–2026

Examiner Intelligence

KIFLE, BRUCK View full profile →

Grants 79% — above average

Career Allowance Rate

1373 granted / 1733 resolved

+19.2% vs TC avg

Strong +16% interview lift

Without

With

+15.9%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

42 currently pending

Career history

1751

Total Applications

across all art units

Statute-Specific Performance

§101

6.0%

-34.0% vs TC avg

§103

12.6%

-27.4% vs TC avg

§102

12.2%

-27.8% vs TC avg

§112

53.9%

+13.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1733 resolved cases

Prosecution Timeline

Oct 04, 2024

Application Filed

Jul 28, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/036,108

Patent 12692240

METHOD FOR PREPARING 3,6-DIAMINOPYRAZINE-2,5-DICARBOXYLIC ACID AND SYNTHETIC INTERMEDIATE THEREOF

3y 2m to grant Granted Jul 28, 2026

18/224,304

Patent 12691097

METHODS AND COMPOSITIONS FOR TREATING POLYOMAVIRUS

3y 0m to grant Granted Jul 28, 2026

18/680,563

Patent 12692229

MASP-2 INHIBITORS AND METHODS OF USE

2y 1m to grant Granted Jul 28, 2026

18/291,846

Patent 12678505

LEAKAGE INHIBITING AGENT FOR LOCAL INJECTION PREPARATION, LOCAL INJECTION PREPARATION INCLUDING THE SAME, AND METHOD FOR PRODUCING LOCAL INJECTION PREPARATION

2y 5m to grant Granted Jul 14, 2026

17/801,757

Patent 12673945

3-((8-((1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

3y 10m to grant Granted Jul 07, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

79%

Grant Probability

95%

With Interview (+15.9%)

1y 10m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1733 resolved cases by this examiner. Grant probability derived from career allowance rate.